![]() |
CiteULike | ![]() |
shimi002's CiteULike | ![]() |
![]() |
|
![]() |
Register | ![]() |
Log in | ![]() |
Del-1, an Endogenous Leukocyte-Endothelial Adhesion Inhibitor, Limits Inflammatory Cell Recruitmentby: Eun Y. Choi, Emmanouil Chavakis, Marcus A. Czabanka, Harald F. Langer, Line Fraemohs, Matina Economopoulou, Ramendra K. Kundu, Alessia Orlandi, Ying Y. Zheng, Darue A. Prieto, Christie M. Ballantyne, Stephanie L. Constant, William C. Aird, Thalia Papayannopoulou, Carl G. Gahmberg, Mark C. Udey, Peter Vajkoczy, Thomas Quertermous, Stefanie Dimmeler, Christian Weber, Triantafyllos Chavakis
|
Reviews
[Write a review of this article]
Find related articles from these CiteULike users
Find related articles with these CiteULike tags
Posting History
AbstractLeukocyte recruitment to sites of infection or inflammation requires multiple adhesive events. Although numerous players promoting leukocyte-endothelial interactions have been characterized, functionally important endogenous inhibitors of leukocyte adhesion have not been identified. Here we describe the endothelially derived secreted molecule Del-1 (developmental endothelial locus-1) as an anti-adhesive factor that interferes with the integrin LFA-1-dependent leukocyte-endothelial adhesion. Endothelial Del-1 deficiency increased LFA-1-dependent leukocyte adhesion in vitro and in vivo. Del-1-/- mice displayed significantly higher neutrophil accumulation in lipopolysaccharide-induced lung inflammation in vivo, which was reversed in Del-1/LFA-1 double-deficient mice. Thus, Del-1 is an endogenous inhibitor of inflammatory cell recruitment and could provide a basis for targeting leukocyte-endothelial interactions in disease. 10.1126/science.1165218
BibTeX record
RIS record